Advertisement
Review Article| Volume 3, ISSUE 1, P115-137, August 2018

Download started.

Ok

Topical Chemotherapy and the Evolving Role of the Biopsy for Ocular Surface Squamous Neoplasia

  • Christine Greer
    Affiliations
    Roski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, 1450 San Pablo Street, Los Angeles, CA 90033, USA
    Search for articles by this author
  • Ashley Polski
    Affiliations
    Roski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, 1450 San Pablo Street, Los Angeles, CA 90033, USA
    Search for articles by this author
  • Jesse L. Berry
    Correspondence
    Corresponding author. 1450 San Pablo Street, Los Angeles, CA 90033.
    Affiliations
    Roski Eye Institute, Department of Ophthalmology, University of Southern California Keck School of Medicine, 1450 San Pablo Street, Los Angeles, CA 90033, USA

    The Vision Center, Department of Ophthalmology, Children’s Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA
    Search for articles by this author
      Ocular surface squamous neoplasia (OSSN) is a conjunctival tumor that is staged based on histopathologic analysis according to the eighth edition (2017) of the American Joint Committee on Cancer’s Cancer Staging Manual.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Ophthalmology and Optometry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lee G.A.
        • Hirst L.W.
        Ocular surface squamous neoplasia.
        Surv Ophthalmol. 1995; 39: 429-450
        • Othman I.S.
        Ocular surface tumors.
        Oman J Ophthalmol. 2009; 2: 3-14
        • Napora C.
        • Cohen E.J.
        • Genvert G.I.
        • et al.
        Factors associated with conjunctival intraepithelial neoplasia: a case control study.
        Ophthalmic Surg. 1990; 21: 27-30
        • Gichuhi S.
        • Sagoo M.S.
        • Weiss H.A.
        • et al.
        Epidemiology of ocular surface squamous neoplasia in Africa.
        Trop Med Int Health. 2013; 18: 1424-1443
      1. Amin M.B. Edge S. Greene F. AJCC cancer staging manual. 8th edition. Springer, New York2017
        • Mittal R.
        • Rath S.
        • Vemuganti G.K.
        Ocular surface squamous neoplasia - review of etio-pathogenesis and an update on clinico-pathological diagnosis.
        Saudi J Ophthalmol. 2013; 27: 177-186
        • Ni C.
        • Searl S.S.
        • Kriegstein H.J.
        • et al.
        Epibulbar carcinoma.
        Int Ophthalmol Clin. 1982; 22: 1-33
        • Erie J.C.
        • Campbell R.J.
        • Liesegang T.J.
        Conjunctival and corneal intraepithelial and invasive neoplasia.
        Ophthalmology. 1986; 93: 176-183
        • Tabin G.
        • Levin S.
        • Snibson G.
        • et al.
        Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia.
        Ophthalmology. 1997; 104: 485-492
        • Sudesh S.
        • Rapuano C.J.
        • Cohen E.J.
        • et al.
        Surgical management of ocular surface squamous neoplasms: the experience from a cornea center.
        Cornea. 2000; 19: 278-283
        • Peksayar G.
        • Soytürk M.K.
        • Demiryont M.
        Long-term results of cryotherapy on malignant epithelial tumors of the conjunctiva.
        Am J Ophthalmol. 1989; 107: 337-340
        • Tunc M.
        • Char D.H.
        • Crawford B.
        • et al.
        Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases.
        Br J Ophthalmol. 1999; 83: 98-103
        • Peksayar G.
        • Altan-Yaycioglu R.
        • Onal S.
        Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours.
        Eye (Lond). 2003; 17: 228-232
        • Crim N.
        • Forniés-Paz M.E.
        • Monti R.
        • et al.
        In situ carcinoma of the conjunctiva: surgical excision associated with cryotherapy.
        Clin Ophthalmol. 2013; 7: 1889-1893
        • Viani G.A.
        • Fendi L.I.
        Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.
        Arq Bras Oftalmol. 2017; 80: 131-136
        • Siedlecki A.N.
        • Tapp S.
        • Tosteson A.N.
        • et al.
        Surgery versus interferon alpha-2b treatment strategies for ocular surface squamous neoplasia: a literature-based decision analysis.
        Cornea. 2016; 35: 613-618
        • Shields J.A.
        • Shields C.L.
        • De Potter P.
        Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan lecture.
        Arch Ophthalmol. 1997; 115: 808-815
        • Seregard S.
        Conjunctival melanoma.
        Surv Ophthalmol. 1998; 42: 321-350
        • Honavar S.G.
        • Manjandavida F.P.
        Tumors of the ocular surface: a review.
        Indian J Ophthalmol. 2015; 63: 187-203
        • Walsh-Conway N.
        • Conway R.M.
        Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion.
        Clin Exp Ophthalmol. 2009; 37: 577-583
        • Gündüz K.
        • Uçakhan O.O.
        • Kanpolat A.
        • et al.
        Nonpreserved human amniotic membrane transplantation for conjunctival reconstruction after excision of extensive ocular surface neoplasia.
        Eye (Lond). 2006; 20: 351-357
        • Espana E.M.
        • Prabhasawat P.
        • Grueterich M.
        • et al.
        Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias.
        Br J Ophthalmol. 2002; 86: 640-645
        • Sepulveda R.
        • Pe'er J.
        • Midena E.
        • et al.
        Topical chemotherapy for ocular surface squamous neoplasia: current status.
        Br J Ophthalmol. 2010; 94: 532-535
        • Nanji A.A.
        • Sayyad F.E.
        • Karp C.L.
        Topical chemotherapy for ocular surface squamous neoplasia.
        Curr Opin Ophthalmol. 2013; 24: 336-342
        • Shields C.L.
        • Kaliki S.
        • Kim H.J.
        • et al.
        Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.
        Cornea. 2013; 32: 248-256
        • Moon C.S.
        • Nanji A.A.
        • Galor A.
        • et al.
        Surgical versus medical treatment of ocular surface squamous neoplasia: a cost comparison.
        Ophthalmology. 2016; 123: 497-504
        • Joag M.G.
        • Gupta A.
        • Galor A.
        • et al.
        Conjunctival intraepithelial neoplasia with mucoepidermoid differentiation: a case report of a subtle lesion.
        Ocul Oncol Pathol. 2015; 1: 278-282
        • Rao N.A.
        • Font R.L.
        Mucoepidermoid carcinoma of the conjunctiva: a clinicopathologic study of five cases.
        Cancer. 1976; 38: 1699-1709
        • Gichuhi S.
        • Macharia E.
        • Kabiru J.
        • et al.
        Clinical presentation of ocular surface squamous neoplasia in Kenya.
        JAMA Ophthalmol. 2015; 133: 1305-1313
        • Thomas B.J.
        • Galor A.
        • Nanji A.A.
        • et al.
        Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.
        Ocul Surf. 2014; 12: 46-58
        • Hirst L.W.
        • Axelsen R.A.
        • Schwab I.
        Pterygium and associated ocular surface squamous neoplasia.
        Arch Ophthalmol. 2009; 127: 31-32
        • Shousha M.A.
        • Karp C.L.
        • Perez V.L.
        • et al.
        Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography.
        Ophthalmology. 2011; 118: 1531-1537
        • Li A.S.
        • Shih C.Y.
        • Rosen L.
        • et al.
        Recurrence of ocular surface squamous neoplasia treated with excisional biopsy and cryotherapy.
        Am J Ophthalmol. 2015; 160: 213-219.e1
        • Kumar D.A.
        • Agarwal A.
        Giant ocular surface squamous neoplasia wrapping whole cornea.
        Eye Contact Lens. 2017; https://doi.org/10.1097/ICL.0000000000000391
        • Galor A.
        • Karp C.L.
        • Oellers P.
        • et al.
        Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
        Ophthalmology. 2012; 119: 1974-1981
        • Maudgil A.
        • Patel T.
        • Rundle P.
        • et al.
        Ocular surface squamous neoplasia: analysis of 78 cases from a UK ocular oncology centre.
        Br J Ophthalmol. 2013; 97: 1520-1524
        • Gichuhi S.
        • Macharia E.
        • Kabiru J.
        • et al.
        Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial.
        Lancet Glob Health. 2016; 4: e378-e385
        • Ishijima K.
        • Kase S.
        • Noda M.
        • et al.
        Pyogenic granuloma developing rapidly after excision of corneal/conjunctival intraepithelial neoplasia.
        Nippon Ganka Gakkai Zasshi. 2010; 114 ([in Japanese]): 1036-1039
        • Stone D.U.
        • Butt A.L.
        • Chodosh J.
        Ocular surface squamous neoplasia: a standard of care survey.
        Cornea. 2005; 24: 297-300
        • Adler E.
        • Turner J.R.
        • Stone D.U.
        Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012.
        Cornea. 2013; 32: 1558-1561
        • Barros J.D.
        • Lowen M.S.
        • Moraes-Filho M.N.
        • et al.
        Use of impression cytology for the detection of unsuspected ocular surface squamous neoplasia cells in pterygia.
        Arq Bras Oftalmol. 2014; 77: 305-309
        • Parrozzani R.
        • Lazzarini D.
        • Dario A.
        • et al.
        In vivo confocal microscopy of ocular surface squamous neoplasia.
        Eye (Lond). 2011; 25: 455-460
        • Adhi M.
        • Duker J.S.
        Optical coherence tomography–current and future applications.
        Curr Opin Ophthalmol. 2013; 24: 213-221
        • Izatt J.A.
        • Hee M.R.
        • Swanson E.A.
        • et al.
        Micrometer-scale resolution imaging of the anterior eye in vivo with optical coherence tomography.
        Arch Ophthalmol. 1994; 112: 1584-1589
        • Bianciotto C.
        • Shields C.L.
        • Guzman J.M.
        • et al.
        Assessment of anterior segment tumors with ultrasound biomicroscopy versus anterior segment optical coherence tomography in 200 cases.
        Ophthalmology. 2011; 118: 1297-1302
        • Kieval J.Z.
        • Karp C.L.
        • Abou Shousha M.
        • et al.
        Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.
        Ophthalmology. 2012; 119: 481-486
        • Atallah M.
        • Joag M.
        • Galor A.
        • et al.
        Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases.
        Ocul Surf. 2017; 15: 688-695
        • De Keizer R.J.
        • Wolff-Rouendaal D.
        • Van Delft J.L.
        Topical application of 5-fluorouracil in premalignant lesions of cornea, conjunctiva, and eyelid.
        Doc Ophthalmol. 1986; 64: 34-42
      2. Section 8: cornea and external disease. Basic clinical and science course. American Academy of Ophthalmology, San Francisco (CA)2015
        • Galor A.
        • Karp C.L.
        • Chhabra S.
        • et al.
        Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
        Br J Ophthalmol. 2010; 94: 551-554
        • Birkholz E.
        • Goins K.
        • Sutphin J.
        • et al.
        Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
        Cornea. 2011; 30: 37-41
        • Bahrami B.
        • Timothy G.
        • Muecke J.S.
        Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
        Clin Exp Ophthalmol. 2014; 42: 317-322
        • Sayed-Ahmed I.O.
        • Palioura S.
        • Galor A.
        • et al.
        Diagnosis and medical management of ocular surface squamous neoplasia.
        Expert Rev Ophthalmol. 2017; 12: 11-19
        • Singh A.
        • Jacques R.
        • Rundle P.A.
        • et al.
        Neoadjuvant topical mitomycin C chemotherapy for conjunctival and corneal intraepithelial neoplasia.
        Eye. 2006; 20: 1092-1094
        • Chen C.
        • Louis D.
        • Dodd T.
        • et al.
        Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.
        Br J Ophthalmol. 2004; 88: 17-18
        • Gupta A.
        • Muecke J.
        Treatment of ocular surface squamous neoplasia with mitomycin C.
        Br J Ophthalmol. 2010; 94: 555-558
        • Ballalai P.L.
        • Erwenne C.M.
        • Martins M.C.
        • et al.
        Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
        Ophthal Plast Reconstr Surg. 2009; 25: 296-299
        • Prabhasawat P.
        • Tarinvorakup P.
        • Tesavibul N.
        • et al.
        Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
        Cornea. 2005; 24: 443-448
        • Shields C.L.
        • Naseripour M.
        • Shields J.A.
        Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
        Am J Ophthalmol. 2002; 133: 601-606
        • Hirst L.W.
        Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia.
        Ophthalmology. 2007; 114: 976-982
        • Blasi A.
        • Maceroni M.
        • Sammarco M.G.
        • et al.
        Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
        Eur J Ophthalmol. 2017; https://doi.org/10.5301/ejo.5001035
        • Shields C.L.
        • Demirci H.
        • Marr B.P.
        • et al.
        Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva.
        Arch Ophthalmol. 2005; 123: 109-113
        • Yeatts R.P.
        • Ford J.G.
        • Stanton C.A.
        • et al.
        Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea.
        Ophthalmology. 1995; 102: 1338-1344
        • Rudkin A.K.
        • Muecke J.S.
        Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia.
        Br J Ophthalmol. 2011; 95: 947-950
        • Parrozzani R.
        • Lazzarini D.
        • Alemany-Rubio E.
        • et al.
        Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
        Br J Ophthalmol. 2011; 95: 355-359
        • Joag M.G.
        • Sise A.
        • Murillo J.C.
        • et al.
        Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia.
        Ophthalmology. 2016; 123: 1442-1448
        • Rudkin A.K.
        • Dempster L.
        • Muecke J.S.
        Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
        Clin Exp Ophthalmol. 2015; 43: 20-25
        • Vann R.R.
        • Karp C.L.
        Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
        Ophthalmology. 1999; 106: 91-97
        • Kim H.J.
        • Shields C.L.
        • Shah S.U.
        • et al.
        Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
        Ophthalmology. 2012; 119: 938
        • Schechter B.
        • Schrier A.
        • Nagler R.
        • et al.
        Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
        Cornea. 2002; 21: 6-11
        • Karp C.L.
        • Galor A.
        • Chhabra S.
        • et al.
        Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia.
        Ophthalmology. 2010; 117: 2241-2246
        • Sturges A.
        • Butt A.L.
        • Lai J.E.
        • et al.
        Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
        Ophthalmology. 2008; 115: 1302.e1
        • Schechter B.A.
        • Koreishi A.F.
        • Karp C.L.
        • et al.
        Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
        Ophthalmology. 2008; 115: 1296.e1
        • Kusumesh R.
        • Ambastha A.
        • Sinha B.
        • et al.
        Topical Interferon α-2b as a single therapy for primary ocular surface squamous neoplasia.
        Asia Pac J Ophthalmol (Phila). 2015; 4: 279-282
        • Yeatts R.P.
        • Engelbrecht N.E.
        • Curry C.D.
        • et al.
        5-fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
        Ophthalmology. 2000; 107: 2190-2195
        • Parrozzani R.
        • Frizziero L.
        • Trainiti S.
        • et al.
        Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
        British Journal of Ophthalmology. 2017; 101: 1094-1099
        • Kusumesh R.
        • Ambastha A.
        • Kumar S.
        • et al.
        Retrospective comparative study of topical interferon α2b versus mitomycin C for primary ocular surface squamous neoplasia.
        Cornea. 2017; 36: 327-331